Trial Condition(s):
Contraception, Ovulation inhibition, Contraceptives, Oral
Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen
Bayer Identifier:
90809
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
516
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
Multi-center, open, uncontrolled study to investigate the efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 21-day regimen for 26 cycles in 504 healthy female subjects
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
